Healthcare Services

Agenus Inc.

3 Forbes Road
Lexington, MA 02421
Click for website

Research Sector Healthcare Services

Summary Description Therapeutics addressing infectious diseases, auto-immune disease and cancer.

Management Garo H. Armen, PH.D, Chairman and CEO; Jonae R. Barnes, Investor Relations Consultant; Ozer Baysal, Chief Business Officer; Robert F. Burns, PhD, Managing Director, 4-Antibody; John Cerio, Vice President, Human Resources & Administration; Christine Klaskin, Vice President, Finance & Principal Financial Officer; Janice McCourt, Vice President, Business Development; Stephen Monks, PhD, Vice President, Manufacturing, Process & Analytical Technologies; Robert Stein, MD, PhD, Chief Scientific Officer; Karen Valentine, JD, Vice President & General Counsel

Click here for Financial Data
Keywords: anti-viral, malaria, oncology, melanoma, lung cancer, shingles, alzheimer's disease, prophage, genital herpes


Updated: Mar. 23, 2018


Agenus is commercializing breakthrough immunotherapies for cancer and infectious diseases. Within the Company's Saponin platform is QS-21 Stimulon, an adjuvant derived from the bark of the Quillaja s......view more

Products / Services

Oncophage, Propage, QS-21Stimulon, HerpV......view more

Technology / Differentiation

Heat shock proteins (HSPs), also called stress proteins, are a group of proteins that are present in all cells (normal cells, cancer cells and infected cells) in all life forms. They act like "chapero...view more

Market / Customers

Vaccines comprise a major part of the healthcare industry and the vaccine market is expected to reach $84.44 billion by 2022 compared to $32 billion in 2013. Adjuvants being a very important part of a......view more